Normal and Malignant Hematopoiesis RAG Seminar - Pierluigi Porcu, MD

The Normal and Malignant Hematopoiesis Research Affinity Group presents a seminar:

Novel Therapies in T-Cell Malignancies: Preclinical and Clinical Studies

Speaker

Pierluigi Porcu, MD
Director, Division of Hematologic Malignancies & Cellular Therapy
Co-Leader, Immune Cell Regulation and Targeting (IRT)
Co-Director, Blood Cancer Center of Excellence (BCCE), Thomas Jefferson University

Questions?

Contact Carolyn A. Felix and Bessy Joseph for questions.